Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Cash & Equivalents (2017 - 2026)

Updated

Regenerative Medical Technology (RMTG) posted Cash & Equivalents of $1.32 million for Q2 2026, down 18.0% from $1.61 million a year earlier but up 24.7% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Cash & Equivalents (2017 - 2026) Analysis & Trends

At the end of FY2025, Regenerative Medical Technology's Cash & Equivalents came in at $956,718, down 17.9% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of 86.4% (FY2020 to FY2025).
  • In prior years, Regenerative Medical Technology's Cash & Equivalents was $1.17 million in FY2024 (+119.7%), $530,540 in FY2023 (-67.8%), $1.65 million in FY2022 (-44.8%) and $2.98 million in FY2021.
  • Quarterly Cash & Equivalents has run from a low of $530,540 in Q4 2023 to a high of $10.73 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Equivalents has declined in each of the last three quarters, with growth averaging 44.8% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 212.4%; the weakest was Q3 2022, with a decline of 83.5%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $1.06 million (Q1 2026), $956,718 (Q4 2025) and $1.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 1.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.32 Mn
Mar 31, 2026 1.06 Mn
Dec 31, 2025 956,718.00
Sep 30, 2025 1.19 Mn
Jun 30, 2025 1.61 Mn
Mar 31, 2025 1.22 Mn
Dec 31, 2024 1.17 Mn
Sep 30, 2024 836,427.00
Jun 30, 2024 617,093.00
Mar 31, 2024 579,352.00
Dec 31, 2023 530,540.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 1.23 Mn
Mar 31, 2023 1.64 Mn
Dec 31, 2022 1.65 Mn
Sep 30, 2022 1.77 Mn
Jun 30, 2022 1.92 Mn
Mar 31, 2022 2.46 Mn
Dec 31, 2021 2.98 Mn
Sep 30, 2021 10.73 Mn
API Access

Regenerative Medical Technology Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RMTG&period=max&api_key=YOUR_API_KEY